Journal
JOURNAL OF THORACIC ONCOLOGY
Volume 12, Issue 1, Pages S1302-S1303Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtho.2016.11.1841
Keywords
atezolizumab; NSCLC; Immunotherapy; Erlotinib